{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T17:00:16Z","timestamp":1788886816101,"version":"build-2803163510"},"reference-count":60,"publisher":"Japanese Society for Hygiene","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Environ Health Prev Med","Environ. Health Prev. Med."],"published-print":{"date-parts":[[2025]]},"DOI":"10.1265\/ehpm.24-00216","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T22:16:54Z","timestamp":1738361814000},"page":"8-8","source":"Crossref","is-referenced-by-count":2,"title":["Lead exposure promotes <i>NF2-wildtype<\/i> meningioma cell proliferation through the Merlin-Hippo signaling pathway"],"prefix":"10.1265","volume":"30","author":[{"given":"Nenghua","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Experimental Diagnosis, Provincial and Municipal Medical Key Disciplines, Jiaxing University Affiliated Traditional Chinese Medicine Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Experimental Diagnosis, Provincial and Municipal Medical Key Disciplines, Jiaxing University Affiliated Traditional Chinese Medicine Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunnong","family":"Yu","sequence":"additional","affiliation":[{"name":"School of International and Public Affairs, Shanghai Jiao Tong University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Public Health, College of Medicine, Jiaxing University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Immunology, College of Medicine, Jiaxing University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Immunology, College of Medicine, Jiaxing University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"335","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Zeng X, et al. E-waste lead exposure and children\u2019s health in China. Sci Total Environ. 2020;734:139286.","DOI":"10.1016\/j.scitotenv.2020.139286"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Pizzol M, Thomsen M, Andersen MS. Long-term human exposure to lead from different media and intake pathways. Sci Total Environ. 2010;408(22):5478\u201388.","DOI":"10.1016\/j.scitotenv.2010.07.077"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Grandjean P. Even low-dose lead exposure is hazardous. Lancet. 2010;376(9744):855\u20136.","DOI":"10.1016\/S0140-6736(10)60745-3"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Marshall AT, et al. Association of lead-exposure risk and family income with childhood brain outcomes. Nat Med. 2020;26(1):91\u20137.","DOI":"10.1038\/s41591-019-0713-y"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Weuve J, et al. Cumulative exposure to lead and cognition in persons with Parkinson\u2019s disease. Mov Disord. 2013;28(2):176\u201382.","DOI":"10.1002\/mds.25247"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Dorea JG. Environmental exposure to low-level lead (Pb) co-occurring with other neurotoxicants in early life and neurodevelopment of children. Environ Res. 2019;177:108641.","DOI":"10.1016\/j.envres.2019.108641"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Levallois P, et al. Public Health Consequences of Lead in Drinking Water. Curr Environ Health Rep. 2018;5(2):255\u201362.","DOI":"10.1007\/s40572-018-0193-0"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Liao LM, et al. Occupational Lead Exposure and Associations with Selected Cancers: The Shanghai Men\u2019s and Women\u2019s Health Study Cohorts. Environ Health Perspect. 2016;124(1):97\u2013103.","DOI":"10.1289\/ehp.1408171"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Steenland K, et al. Cancer incidence among workers with blood lead measurements in two countries. Occup Environ Med. 2019;76(9):603\u201310.","DOI":"10.1136\/oemed-2019-105786"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Meng Y, et al. Exposure to lead increases the risk of meningioma and brain cancer: A meta-analysis. J Trace Elem Med Biol. 2020;60:126474.","DOI":"10.1016\/j.jtemb.2020.126474"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Leroyer A, et al. Cancer mortality and chemical exposure in a retrospective zinc and lead smelter cohort: A 48-year follow-up. Int J Hyg Environ Health. 2022;242:113955.","DOI":"10.1016\/j.ijheh.2022.113955"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kotecha RS, et al. Meningiomas in children and adolescents: a meta-analysis of individual patient data. Lancet Oncol. 2011;12(13):1229\u201339.","DOI":"10.1016\/S1470-2045(11)70275-3"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Goldbrunner R, et al. EANO guideline on the diagnosis and management of meningiomas. Neuro Oncol. 2021;23(11):1821\u201334.","DOI":"10.1093\/neuonc\/noab150"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Louis DN, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021;23(8):1231\u201351.","DOI":"10.1093\/neuonc\/noab106"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Cordova C, Kurz SC. Advances in Molecular Classification and Therapeutic Opportunities in Meningiomas. Curr Oncol Rep. 2020;22(8):84.","DOI":"10.1007\/s11912-020-00937-4"},{"key":"16","unstructured":"16. Suppiah S, et al. Molecular and translational advances in meningiomas. Neuro Oncol. 2019;21(Suppl 1):i4\u201317."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Bachir S, et al. Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis. Int J Mol Sci. 2021;22(2).","DOI":"10.3390\/ijms22020690"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Lee S, et al. The Role of Merlin\/NF2 Loss in Meningioma Biology. Cancers (Basel). 2019;11(11).","DOI":"10.3390\/cancers11111633"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Petrilli AM, Fernandez-Valle C. Role of Merlin\/NF2 inactivation in tumor biology. Oncogene. 2016;35(5):537\u201348.","DOI":"10.1038\/onc.2015.125"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Mota M, Shevde LA. Merlin regulates signaling events at the nexus of development and cancer. Cell Commun Signal. 2020;18(1):63.","DOI":"10.1186\/s12964-020-00544-7"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Mei Y, et al. Genomic profile of human meningioma cell lines. PLoS One. 2017;12(5):e0178322.","DOI":"10.1371\/journal.pone.0178322"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Khan M, et al. Modeling Meningiomas: Optimizing Treatment Approach. Neurosurg Clin N Am. 2023;34(3):479\u201392.","DOI":"10.1016\/j.nec.2023.02.014"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Wu Q, et al. Forkhead Box M1 promotes the growth and tube formation of human malignant meningioma cells via the aryl hydrocarbon receptor signaling pathway. Folia Neuropathol. 2020;58(3):223\u201336.","DOI":"10.5114\/fn.2020.100065"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Zhang X, et al. Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Res. 2010;70(6):2350\u20138.","DOI":"10.1158\/0008-5472.CAN-09-3885"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Ma S, et al. The Hippo Pathway: Biology and Pathophysiology. Annu Rev Biochem. 2019;88:577\u2013604.","DOI":"10.1146\/annurev-biochem-013118-111829"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Dey A, Varelas X, Guan KL. Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine. Nat Rev Drug Discov. 2020;19(7):480\u201394.","DOI":"10.1038\/s41573-020-0070-z"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Cunningham R, Hansen CG. The Hippo pathway in cancer: YAP\/TAZ and TEAD as therapeutic targets in cancer. Clin Sci (Lond). 2022;136(3):197\u2013222.","DOI":"10.1042\/CS20201474"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Liu-Chittenden Y, et al. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes Dev. 2012;26(12):1300\u20135.","DOI":"10.1101\/gad.192856.112"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Kwon JW, et al. Combined inhibition of Bcl-2 family members and YAP induces synthetic lethality in metastatic gastric cancer with RASA1 and NF2 deficiency. Mol Cancer. 2023;22(1):156.","DOI":"10.1186\/s12943-023-01857-0"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Laraba L, et al. Inhibition of YAP\/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma. Brain. 2023;146(4):1697\u2013713.","DOI":"10.1093\/brain\/awac342"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Szulzewsky F, et al. Both YAP1-MAML2 and constitutively active YAP1 drive the formation of tumors that resemble NF2 mutant meningiomas in mice. Genes Dev. 2022;36(13\u201314):857\u201370.","DOI":"10.1101\/gad.349876.122"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Guerrero PA, et al. Oncogenic role of Merlin\/NF2 in glioblastoma. Oncogene. 2015;34(20):2621\u201330.","DOI":"10.1038\/onc.2014.185"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Ye K. Phosphorylation of merlin regulates its stability and tumor suppressive activity. Cell Adh Migr. 2007;1(4):196\u20138.","DOI":"10.4161\/cam.1.4.5192"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Waldt N, et al. Crispr\/Cas-based modeling of NF2 loss in meningioma cells. J Neurosci Methods. 2021;356:109141.","DOI":"10.1016\/j.jneumeth.2021.109141"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Mani T, et al. FERM domain phosphoinositide binding targets merlin to the membrane and is essential for its growth-suppressive function. Mol Cell Biol. 2011;31(10):1983\u201396.","DOI":"10.1128\/MCB.00609-10"},{"key":"36","unstructured":"36. Parry DM, et al. Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities. Am J Hum Genet. 1996;59(3):529\u201339."},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Ikeda K, et al. Inhibition of NF2-negative and NF2-positive primary human meningioma cell proliferation by overexpression of merlin due to vector-mediated gene transfer. J Neurosurg. 1999;91(1):85\u201392.","DOI":"10.3171\/jns.1999.91.1.0085"},{"key":"38","unstructured":"38. Wang Z, Shen X, Zhu J. Lead Exposure Promotes the Proliferation, Migration and Invasion of Meningioma Cells via the Merlin-mTOR Signaling Pathway. Chin J Biochem Mol Biol. 2023;39(2):234\u201343."},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Crosio C, et al. Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian Aurora kinases. Mol Cell Biol. 2002;22(3):874\u201385.","DOI":"10.1128\/MCB.22.3.874-885.2002"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Calabrese EJ, Baldwin LA. Lead-induced cell proliferation and organ-specific tumorigenicity. Drug Metab Rev. 1992;24(3):409\u201316.","DOI":"10.3109\/03602539208996299"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Vogetseder A, et al. Proliferation capacity of the renal proximal tubule involves the bulk of differentiated epithelial cells. Am J Physiol Cell Physiol. 2008;294(1):C22\u20138.","DOI":"10.1152\/ajpcell.00227.2007"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Zanconato F, Cordenonsi M, Piccolo S. YAP\/TAZ at the Roots of Cancer. Cancer Cell. 2016;29(6):783\u2013803.","DOI":"10.1016\/j.ccell.2016.05.005"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Tang TT, et al. Small Molecule Inhibitors of TEAD Auto-palmitoylation Selectively Inhibit Proliferation and Tumor Growth of NF2-deficient Mesothelioma. Mol Cancer Ther. 2021;20(6):986\u201398.","DOI":"10.1158\/1535-7163.MCT-20-0717"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Fang L, et al. SET1A-Mediated Mono-Methylation at K342 Regulates YAP Activation by Blocking Its Nuclear Export and Promotes Tumorigenesis. Cancer Cell. 2018;34(1):103\u201318.e9.","DOI":"10.1016\/j.ccell.2018.06.002"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Sahebjam S, Gilbert MR. Modeling YAP fusions: a paradigm for investigating rare cancers? Genes Dev. 2022;36(15\u201316):874\u20135.","DOI":"10.1101\/gad.350069.122"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Nobee A, et al. Atypical Intraparenchymal Meningioma with YAP1-MAML2 Fusion in a Young Adult Male: A Case Report and Mini Literature Review. Int J Mol Sci. 2023;24(16).","DOI":"10.3390\/ijms241612814"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Sievers P, et al. YAP1-fusions in pediatric NF2-wildtype meningioma. Acta Neuropathol. 2020;139(1):215\u20138.","DOI":"10.1007\/s00401-019-02095-9"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Schieffer KM, et al. YAP1-FAM118B Fusion Defines a Rare Subset of Childhood and Young Adulthood Meningiomas. Am J Surg Pathol. 2021;45(3):329\u201340.","DOI":"10.1097\/PAS.0000000000001597"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Honda D, Okumura M, Chihara T. Crosstalk between the mTOR and Hippo pathways. Dev Growth Differ. 2023;65(6):337\u201347.","DOI":"10.1111\/dgd.12867"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Muranen T, et al. The Hippo pathway effector YAP1 contributes to escape from proliferation arrest under chronic PI3K\/mTOR inhibition. Mol Cancer Ther. 2015;14(7).","DOI":"10.1158\/1538-8514.PI3K14-PR03"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Nelson N, Clark GJ. Rheb may complex with RASSF1A to coordinate Hippo and TOR signaling. Oncotarget. 2016;7(23):33821\u201331.","DOI":"10.18632\/oncotarget.8447"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Gan W, et al. LATS suppresses mTORC1 activity to directly coordinate Hippo and mTORC1 pathways in growth control. Nat Cell Biol. 2020;22(2):246\u201356.","DOI":"10.1038\/s41556-020-0463-6"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Kudryashova TV, et al. HIPPO-Integrin-linked Kinase Cross-Talk Controls Self-Sustaining Proliferation and Survival in Pulmonary Hypertension. Am J Respir Crit Care Med. 2016;194(7):866\u201377.","DOI":"10.1164\/rccm.201510-2003OC"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Liu Y, et al. The hypoxia conditioned mesenchymal stem cells promote hepatocellular carcinoma progression through YAP mediated lipogenesis reprogramming. J Exp Clin Cancer Res. 2019;38(1):228.","DOI":"10.1186\/s13046-019-1219-7"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Mazandaran AA, Khodarahmi P. The protective role of Coenzyme Q10 in metallothionein-3 expression in liver and kidney upon rats\u2019 exposure to lead acetate. Mol Biol Rep. 2021;48(4):3107\u201315.","DOI":"10.1007\/s11033-021-06311-2"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Gu C, et al. Lead and cadmium synergistically enhance the expression of divalent metal transporter 1 protein in central nervous system of developing rats. Neurochem Res. 2009;34(6):1150\u20136.","DOI":"10.1007\/s11064-008-9891-6"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Lu H, Guizzetti M, Costa LG. Inorganic lead stimulates DNA synthesis in human astrocytoma cells: role of protein kinase Calpha. J Neurochem. 2001;78(3):590\u20139.","DOI":"10.1046\/j.1471-4159.2001.00434.x"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Posser T, et al. Exposure of C6 glioma cells to Pb(II) increases the phosphorylation of p38(MAPK) and JNK1\/2 but not of ERK1\/2. Arch Toxicol. 2007;81(6):407\u201314.","DOI":"10.1007\/s00204-007-0177-6"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Boratko A, Csortos C. TIMAP, the versatile protein phosphatase 1 regulator in endothelial cells. IUBMB Life. 2017;69(12):918\u201328.","DOI":"10.1002\/iub.1695"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Boratko A, Csortos C. PKC mediated phosphorylation of TIMAP regulates PP1c activity and endothelial barrier function. Biochim Biophys Acta Mol Cell Res. 2017;1864(2):431\u20139.","DOI":"10.1016\/j.bbamcr.2016.12.001"}],"container-title":["Environmental Health and Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ehpm\/30\/0\/30_24-00216\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T05:11:55Z","timestamp":1738386715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ehpm\/30\/0\/30_24-00216\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":60,"journal-issue":{"issue":"0","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1265\/ehpm.24-00216","relation":{},"ISSN":["1342-078X","1347-4715"],"issn-type":[{"value":"1342-078X","type":"print"},{"value":"1347-4715","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"24-00216"}}